Publication

Article

Supplements and Featured Publications

Biosimilars for Immune-Mediated Inflammatory Diseases: 2022 Update
Volume28
Issue 12

What are the current challenges to wider biosimilar use in the United States?

Plain Language Summary

Plain Language Summary

Click the image to open in a new window.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo